PROCEPT BioRobotics Corp (NAS:PRCT)
$ 62 -0.04 (-0.06%) Market Cap: 3.19 Bil Enterprise Value: 3.04 Bil PE Ratio: 0 PB Ratio: 12.07 GF Score: 40/100

Q1 2022 Procept Biorobotics Corp Earnings Call Transcript

May 05, 2022 / 08:30PM GMT
Release Date Price: $35.13 (-5.59%)
Matthew James Bacso
Gilmartin Group LLC - Principal

Thanks, operator. Good afternoon, and thank you for participating in today's call. Joining me from PROCEPT BioRobotics are Reza Zadno, CEO; and Kevin Waters, CFO. Earlier today, PROCEPT released financial results for the quarter ended March 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.

All forward-looking statements, including, without limitation, those related to our sales and operating trends and future financial performance, expense management expectations for hiring or growth, market opportunity, revenue guidance, commercial expansion, the impact of COVID-19 on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot